These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21228361)

  • 41. Increased expression of oncogene-induced senescence markers during cervical squamous cell cancer development.
    Zhang Y; Guo L; Xing P; Chen Y; Li F; Zhu W; Lu X
    Int J Clin Exp Pathol; 2014; 7(12):8911-6. PubMed ID: 25674264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variability of pathologists' utilization of p16 and ki-67 immunostaining in the diagnosis of cervical biopsies in routine pathology practice and its impact on the frequencies of cervical intraepithelial neoplasia diagnoses and cytohistologic correlations.
    Singh C; Manivel JC; Truskinovsky AM; Savik K; Amirouche S; Holler J; Thyagarajan B; Gulbahce HE; Pambuccian SE
    Arch Pathol Lab Med; 2014 Jan; 138(1):76-87. PubMed ID: 24377814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of p16, CK17, p63, and human papillomavirus in diagnosis of cervical intraepithelial neoplasia and distinction from its mimics.
    Selvi K; Badhe BA; Papa D; Ganesh RN
    Int J Surg Pathol; 2014 May; 22(3):221-30. PubMed ID: 23883975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased D2-40 and increased p16INK4A immunoreactivities correlate with higher grade of cervical intraepithelial neoplasia.
    Han H; Yang Y; Lu Z; He Q; Lin Z
    Diagn Pathol; 2011 Jul; 6():59. PubMed ID: 21729305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different patterns of p16 immunoreactivity in cervical biopsies: correlation to lesion grade and HPV detection, with a review of the literature.
    Kostopoulou E; Samara M; Kollia P; Zacharouli K; Mademtzis I; Daponte A; Messinis IE; Koukoulis G
    Eur J Gynaecol Oncol; 2011; 32(1):54-61. PubMed ID: 21446326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Shain AF; Kwok S; Folkins AK; Kong CS
    Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
    Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
    Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
    Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
    Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heat shock protein 27 and p16 immunohistochemistry in cervical intraepithelial neoplasia and squamous cell carcinoma.
    Tozawa-Ono A; Yoshida A; Yokomachi N; Handa R; Koizumi H; Kiguchi K; Ishizuka B; Suzuki N
    Hum Cell; 2012 Mar; 25(1):24-8. PubMed ID: 22302674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
    Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
    Alshenawy HA
    Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.
    Dijkstra MG; Heideman DA; de Roy SC; Rozendaal L; Berkhof J; van Krimpen K; van Groningen K; Snijders PJ; Meijer CJ; van Kemenade FJ
    J Clin Pathol; 2010 Nov; 63(11):972-7. PubMed ID: 20924035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of p16(INK4a) immunohistochemistry staining on interobserver agreement on the diagnosis of cervical intraepithelial neoplasia.
    Pacchiarotti A; Galeotti S; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
    Am J Clin Pathol; 2014 Mar; 141(3):367-73. PubMed ID: 24515764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fascin expression in cervical normal squamous epithelium, cervical intraepithelial neoplasia, and superficially invasive (stage IA1) squamous carcinoma of the cervix.
    Koay MH; Crook M; Stewart CJ
    Pathology; 2014 Aug; 46(5):433-8. PubMed ID: 24977742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens.
    Yu L; Wang L; Zhong J; Chen S
    Cancer Cytopathol; 2010 Feb; 118(1):47-55. PubMed ID: 20069634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias.
    Venturoli S; Ambretti S; Mirasoli M; Santini D; Zerbini M; Roda A; Musiani M
    Int J Gynecol Pathol; 2008 Oct; 27(4):575-81. PubMed ID: 18753961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance.
    Guo M; Warriage I; Mutyala B; Patel S; Lin E; Gong Y; Sneige N
    Diagn Cytopathol; 2011 Jul; 39(7):482-8. PubMed ID: 20607682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic value of HMGB1 immunostaining on cell blocks from residual liquid-based gynecologic cytology specimens.
    Yu L; Duan C; He M; Yang Z; Chen G; Shi H; Yang S; Wang L; Chen S
    Diagn Cytopathol; 2014 Sep; 42(9):802-8. PubMed ID: 24550226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.